AsyncHealth

The mental-healthcare system is overwhelmed. Patients wait months for care and clinicians struggle with burnout.

AsyncHealth has created a solution. It’s a telehealth company that’s created a digital platform designed to reduce long wait times by enabling Artificial Intelligence-powered consultations. Instead of waiting months for care, patients can consult with a lifelike AI virtual agent in as little as twenty-four hours.

AsyncHealth is led by a team with extensive experience in both telemedicine and mental healthcare. Co-Founder Dr. Peter Yellowlees was President of the American Telemedicine Association. And Chief Technology Officer Steven Chan chaired on the Committee on Innovation at the American Psychiatric Association.

This company is targeting the ninety-one-billion-dollar market for behavioral health, a market that’s riddled with problems.

Long waitlists, increased hospital stays, and clinician burnout are the result of overwhelming demand. And current Telehealth solutions only provide real-time care.

Every year, fifty-four percent of patients receive the wrong treatment. And lost productivity costs run as high as $100 billion in the U.S. alone.

AsyncHealth disrupts the outdated model by enabling AI-driven consultations. Instead of waiting for an appointment, patients engage in virtual video interviews with AI virtual agents, which gather responses and generate clinical summaries.

Opening up to an AI agent may seem strange. But in a clinical trial at the University of California Davis, the software earned an eighty-four-percent patient satisfaction rate.

Said one patient, “I prefer an avatar to a real person because I know an avatar cannot judge me, which makes me feel more comfortable opening up about my mental health.”

Said another, “It was very easy to record my answers, upload, and re-record!”

AsyncHealth operates a business-to-business (B2B) software-as-a-service (SaaS) business model. It offers its service to private clinics, telehealth providers, educational institutions, and health systems.

The company has completed three successful clinical trials involving 550 patients, and has been featured in fifteen peer-reviewed publications.

AsyncHealth has received seven million dollars in grants from the National Institutes of Health (NIH) and has pending patents covering its technology.

Team Background

Peter Yellowlees - Director & CEO

Peter is a psychiatrist with extensive experience dealing with mental-health consultations.

For twenty-two years, he’s worked at the University of California, Davis as a professor of Psychiatry. He also taught for nearly a decade at the University of Queensland.

Previously he was President of the American Telemedicine Association. He earned a Bachleor’s degree in Medicine from University College London and an MD from Flinders University in Australia.

Steven Chan - Co-Founder & CTO

Prior to starting AsyncHealth, Steven worked for ADviCE Health, a company linking digital-health software developers with health-system providers. Before that, he served on the faculty at Stanford University’s School of Medicine.

For the past ten years, he’s chaired on the Committee on Innovation with the American Psychiatric Association. Earlier in his career, he was a technology analyst with Kaiser Permanente, a healthcare company, and was a software-development engineer with Microsoft.

Steven earned Bachelor’s degrees in Computer Science and Molecular Cell Biology from UC Berkeley and an MD from UC Irvine.

Barbara Yellowlees - Chief Operating Officer

Barbara has experience in the health-technology industry.

She previously founded HealthLinkNow, a telemedicine company that was acquired by a Fortune 500 company in 2016. She’s also held leadership role at RoboPath, a robotics company, and the Medical Board of California.

She studied Health and Business at Sonoma State University.

Co-Investors